In an interview with the New York Times, Rebecca Boxer, MD, discusses how a new clinical trial will serve a population greatly in need of targeted COVID-19 treatments.
A study published in the New England Journal of Medicine, led by Lisa A. Jackson, MD, of Kaiser Permanente’s Washington Health Research Institute, reports on promising results in the phase 1 trial of an experimental COVID-19 vaccine.
Collaboration between Kaiser Permanente’s care delivery system and research programs has driven the successful implementation of remdesivir clinical trials across regions.
Greg Simon, MD, MPH, a psychiatrist with Washington Permanente Medical Group, told Health that situational depression occurs after a life event – such as job loss, death of a loved one, or serious illness diagnosis – that leaves the person feeling stressed or upset.
Imelda Dacones, MD, president and CEO of Northwest Permanente, says physicians have an obligation to reduce the causes and mitigate the effects of climate change.
Over the last several weeks, an outpouring of gratitude and support for those working tirelessly on the front lines to combat COVID-19 has filled social media.
Stephen M. Parodi, MD, associate executive director for The Permanente Medical Group, shared with Time magazine some of the ways Kaiser Permanente is using telemedicine to help combat the spread of coronavirus.
With more cases of coronavirus (COVID-19) emerging in the United States, Permanente physicians are stepping up to serve affected communities and share important information.
Richard S. Isaacs, MD, FACS, addresses the effects of consumerism on health care and the importance of delivering consistent exceptional care to patients.
This session at South by Southwest 2020 will feature thought leaders from The Permanente Federation, The SCAN Foundation, and California Health Care Foundation.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.